Coronary atherosclerosis due to lipid rich plaque
ICD-10 I25.83 is a billable code used to indicate a diagnosis of coronary atherosclerosis due to lipid rich plaque.
Coronary atherosclerosis due to lipid-rich plaque is a specific form of coronary artery disease characterized by the accumulation of lipids within the arterial walls, leading to the formation of atherosclerotic plaques. Clinically, patients may present with symptoms such as angina pectoris, shortness of breath, or may be asymptomatic until an acute coronary event occurs. The coronary arteries, which supply blood to the heart muscle, become narrowed or blocked due to these plaques, resulting in reduced blood flow. Disease progression can lead to ischemic heart disease, myocardial infarction, or sudden cardiac death. Diagnostic considerations include imaging studies such as coronary angiography, CT angiography, and non-invasive tests like stress testing. Laboratory tests may also be performed to assess lipid levels and other cardiovascular risk factors. Understanding the anatomy involved, particularly the coronary arteries and their branches, is crucial for effective diagnosis and management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I25.83 specifically covers coronary atherosclerosis characterized by lipid-rich plaques. This includes conditions where lipid accumulation leads to significant narrowing of coronary arteries, potentially resulting in ischemic heart disease or myocardial infarction.
I25.83 should be used when there is clear documentation of coronary atherosclerosis due to lipid-rich plaque, distinguishing it from other forms of atherosclerosis that may not involve lipid-rich components.
Documentation should include imaging results showing lipid-rich plaques, clinical symptoms consistent with coronary artery disease, and any relevant laboratory results indicating lipid levels. Detailed clinical notes that describe the patient's condition and treatment plan are also essential.
